Prescription drug · NDA AUTHORIZED GENERIC
Pyrimethamine NDC 72647-330
Pyrimethamine 25 mg/1 · Tablet · Oral · OAKRUM PHARMA, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72647-330-01 | 72647033001 | 100 TABLET in 1 BOTTLE, PLASTIC (72647-330-01)Marketed from Mar 13, 2020 | |
| 72647-330-03 | 72647033003 | 30 TABLET in 1 BOTTLE, PLASTIC (72647-330-03)Marketed from Mar 13, 2020 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Pyrimethamine
- Generic name (nonproprietary)
- pyrimethamine
- Active ingredients
- Pyrimethamine — 25 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- OAKRUM PHARMA, LLC
- Product type
- Prescription drug
- Marketing category
- NDA authorized genericApplication NDA 008578
- Marketing start
- Listing expires
- Other FDA classes
- Dihydrofolate Reductase Inhibitors (Mechanism)
- Identifiers
- Product ID 72647-330_d61ffa19-149f-4402-884a-4d16becb80baSPL ID d61ffa19-149f-4402-884a-4d16becb80baSPL set ID 8ed8141b-e6c0-4a6b-8a08-2858c8c8bd4aRxCUI 198182UNII Z3614QOX8WUPC 0372647330018, 0372647330032
- Pharmacologic class
- Dihydrofolate Reductase Inhibitor Antimalarial
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N472647033001followed by a unit qualifier and the quantityPackage 72647-0330-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Treatment of Toxoplasmosis: Pyrimethamine is indicated for the treatment of toxoplasmosis when used conjointly with a sulfonamide, since synergism exists with this combination.
Excerpt only. Read the full label for complete information.
Other NDCs under NDA 008578
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.